No Safety Concerns With DTaP Combo Vaccine for Kids: Study

By E.J. Mundell
HealthDay Reporter

FRIDAY, June 8, 2018 (HealthDay News) — A comprehensive, nearly two-decades long study of the DTaP vaccine that’s routinely given to babies and young children finds no safety issues.

“No new or unexpected adverse events were detected” with use of the diphtheriatetanus-acellular pertussis (DTaP) shot over 19 years of follow-up, concluded a team led by Dr. Pedro Moro, of the U.S. Centers for Disease Control and Prevention.

The shot protects against three potentially serious infectious diseases of childhood, including whooping cough (pertussis). In recent years, the “anti-vaxxer” movement — a small minority of parents — has raised concerns that routine childhood immunizations might carry long-term health risks for kids.

These concerns persist despite numerous studies showing no link between childhood vaccines and conditions such as autoimmune dysfunction or autism.

Leave a Reply

Your email address will not be published. Required fields are marked *